物质信息

ID:176797

名称和标识
商标名
Arixtra
IUPAC标准名
decasodium (2S,3S,4R,5R,6R)-6-{[(2R,3R,4R,5R,6R)-6-{[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-{[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-[(sulfonatooxy)methyl]oxan-3-yl]oxy}-5-(sulfonatooxy)oxan-3-yl]oxy}-5-(sulfonatoamino)-4-(sulfonatooxy)-2-[(sulfonatooxy)methyl]oxan-3-yl]oxy}-3-{[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-[(sulfonatooxy)methyl]oxan-2-yl]oxy}-4,5-dihydroxyoxane-2-carboxylate
IUPAC传统名
decasodium (2S,3S,4R,5R,6R)-6-{[(2R,3R,4R,5R,6R)-6-{[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-{[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-[(sulfonatooxy)methyl]oxan-3-yl]oxy}-5-(sulfonatooxy)oxan-3-yl]oxy}-5-(sulfonatoamino)-4-(sulfonatooxy)-2-[(sulfonatooxy)methyl]oxan-3-yl]oxy}-3-{[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-[(sulfonatooxy)methyl]oxan-2-yl]oxy}-4,5-dihydroxyoxane-2-carboxylate
别名
Fondaparinux
数据登录号
Chemspider ID
DrugBank ID
ATC码
维基百科标题
CHEMBL
美国药典/FDA物质标识码
PubChem CID
化合物性质
药理学性质
给药途径
subcutaneous
欧盟(EMEA)药品许可证
Arixtra
半衰期
17-21 hours
法定药品分级
Rx-only (US)
POM (UK)
蛋白结合率
94%
生物利用度
N/A
美国(FDA)药品许可证
Fondaparinux
代谢
renally excreted unchanged
描述信息
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据